Venaxis (APPY) Cash Flow Statement

Click line-items for a historical chart and %

Net loss
Stock-based compensation for services	368.46K
Depreciation and amortization	97K
Amortization of license fee
Impairment charges
Accounts receivable	-602
Inventories
Prepaid expenses and other current assets	224.25K
Accounts payable	-521.6K
Accrued liabilities
Accrued compensation
Deferred revenue
Net cash used in operating activities
Purchases of short-term investments	-13.82M
Sales of short-term investments	16.52M
Purchases of property and equipment
Patent and trademark acquisition costs	-14.38K
Net cash used in investing activities
Repayment of notes payable and other obligation	-229.24K
Proceeds from exercise of stock warrants and options
Net proceeds from issuance of common stock
Net cash (used in) provided by financing activities
Net decrease in cash and cash equivalents	435.04K
Cash and cash equivalents at beginning of period	2.01M
Cash and cash equivalents at end of period	2.45M
Cash paid during the period for interest	33.33K

Entities mentioned with APPY

View All Entities